butabarbital will reduce the extent or influence of doravirine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. butabarbital will lessen the level or effect of levamlodipine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. butabarbital will minimize the lev